This application is to establish the UNC-Malawi Cancer Consortium (UNC-MCC), to develop capacity and conduct high-impact research focused on HIV-associated cancers. The consortium builds on longstanding collaborations between the University of North Carolina at Chapel Hill (UNC-CH), Lighthouse Trust, Malawi Ministry of Health (MOH), and University of Malawi College of Medicine (COM). These partnerships have resulted in internationally recognized contributions for HIV care and prevention in sub-Saharan Africa. This infrastructure can now be leveraged for HIV-associated malignancies. UNC-MCC is focused on the herpesvirus-associated cancers, Kaposi sarcoma (KS), and lymphoma. Our consortium will be led by three principal investigators with highly complementary expertise (Satish Gopal MD, clinical research;Sam Phiri PhD, implementation science;Blossom Damania PhD, virology). The third research project undertaken by UNC-MCC attempts to develop risk-adapted, response-guided treatment concepts for HIV-associated lymphoma in Malawi. The project is led by three co-PIs, Drs. Satish Gopal (UNC Project-Malawi), Yohannie MIombe (COM), and Richard Nyasosela (MOH). Lymphoma is the most curable cancer among HIV-infected individuals in Malawi, and this project addresses the central problem that many patients likely receive more chemotherapy than is needed to cure them. This increases treatment-related complications in a setting where supportive care is limited, and compromises long-term survival. An ability to beti:er identify patients who are curable with less chemotherapy can optimize the balance between efficacy and toxicity. We will attempt to develop more risk-adapted and response-guided approaches to lymphoma treatment through the following aims: (1) to identify clinical variables and peripheral blood biomarkers associated with rapid achievement of durable clinical remission among HIV-associated lymphoma patients in Malawi;and (2) to identify tumor characteristics, including gene expression profiles, which are also associated with rapid achievement of durable clinical remission.
These aims will build on existing work in Lilongwe as part of the NIH-funded KCH Lymphoma Study, enhanced by collaborators from the UNC-CH Vironomics Core and sequencing infrastructure developed to support UNC-CH participation in The Cancer Genome Atlas (TCGA) project. Leveraging these ample resources, the proposed research will yield insights which are informative to care of HIV-associated lymphoma throughout sub-Saharan Africa.

Public Health Relevance

The UNC-Malawi Cancer Consortium will address herpesvirus-associated cancers in HIV-infected individuals. Its third project aims to improve long-term survival for HIV-associated lymphoma, by identifying patients who can be cured with less chemotherapy, minimizing treatment-related toxicity in a setting where supportive care is extremely limited.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54CA190152-01
Application #
8933167
Study Section
Special Emphasis Panel (ZCA1-RPRB-O (M2))
Program Officer
Dominguez, Geraldina
Project Start
2014-09-15
Project End
2019-08-31
Budget Start
2014-09-15
Budget End
2015-08-31
Support Year
1
Fiscal Year
2014
Total Cost
$164,099
Indirect Cost
$34,457
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Dhungel, Bal Mukunda; Montgomery, Nathan D; Painschab, Matthew S et al. (2018) 'Discovering' primary effusion lymphoma in Malawi. AIDS 32:2264-2266
Khan, Shiraz; Liomba, George; Rosenberg, Nora E et al. (2018) Utilization of fine needle aspiration cytology at Kamuzu central hospital. PLoS One 13:e0196561
Montgomery, Nathan D; Tomoka, Tamiwe; Krysiak, Robert et al. (2018) Practical Successes in Telepathology Experiences in Africa. Clin Lab Med 38:141-150
El-Mallawany, Nader Kim; Kamiyango, William; Villiera, Jimmy et al. (2018) Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol :1-7
Painschab, Matthew; Gopal, Satish (2018) Guidelines for sub-Saharan Africa: a call for evidence. Lancet Oncol 19:445-446
Hosseinipour, Mina C; Kang, Minhee; Krown, Susan E et al. (2018) As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis 67:251-260
Painschab, Matthew S; Kasonkanji, Edwards; Zuze, Takondwa et al. (2018) Mature outcomes and prognostic indices in diffuse large B-cell lymphoma in Malawi: a prospective cohort. Br J Haematol :
Horner, Marie-Jos├Ęphe; Salima, Ande; Chilima, Chrissie et al. (2018) Frequent HIV and Young Age Among Individuals With Diverse Cancers at a National Teaching Hospital in Malawi. J Glob Oncol :1-11
Zuze, Takondwa; Painschab, Matthew S; Seguin, Ryan et al. (2018) Plasmablastic lymphoma in Malawi. Infect Agent Cancer 13:22
Tomoka, Tamiwe; Montgomery, Nathan D; Powers, Eric et al. (2018) Lymphoma and Pathology in Sub-Saharan Africa: Current Approaches and Future Directions. Clin Lab Med 38:91-100

Showing the most recent 10 out of 47 publications